Human_GAPDH_F_SW Sequence:AAG GG and 27 more items

The University of Nebraska Medical Center (UNMC), a state institution operating under the Board of Regents of the University of Nebraska, awarded a purchase order valued at $121.62 to Integrated DNA Technologies Inc. (IDT), a vendor located in Chicago, Illinois. The contract was executed on June 11, 2026, with a delivery completion date of June 18, 2026. Goods are to be delivered to UNMC General Supply located at 601 South Saddle Creek Road, Omaha, Nebraska 68106. Payment terms are Net 30 with freight prepaid and F.O.B. destination, governed by the University of Nebraska Standard Terms of Purchase unless superseded by an existing vendor agreement.

The purchase order comprises 20 line items consisting of synthetic oligonucleotide sequences (primers) for human gene expression analysis. The primers are designed for reverse transcription polymerase chain reaction (RT-PCR) applications targeting ten human genes: glyceraldehyde 3-phosphate dehydrogenase (GAPDH), matrix metalloproteinases (MMP-13 and MMP-3), a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS-4), type II collagen (COL2A1), aggrecan, sex-determining region Y-box 9 (SOX9), interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX2). Individual unit prices for the forward and reverse primer sequences range from $5.24 to $6.98 per sequence.